Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Small, specific inhibitors of VLA4-mediated cell adhesion from Biogen

March 13, 1997

Improved immunomodulating agent described by SKB

March 13, 1997

Cell adhesion inhibitors disclosed by Nippon Shinyaku

March 12, 1997

Gelatinase inhibitors prepared by Ono

March 11, 1997

MMP inhibitors from Ono

March 10, 1997

U.S. patent covers Immunex's TNFR

March 7, 1997

IVAX receives approval for generic NSAID

March 6, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Protein kinase inhibitors reported by Roche

March 5, 1997

Teva's Tolmetin approved

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...